Evidence map›Paper›PMID 18778568›Full record

ReviewCurrent osteoporosis reports2008

Parathyroid hormone and the cardiovascular system.

Lorraine A Fitzpatrick, John P Bilezikian, Shonni J Silverberg

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current osteoporosis reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2018
    Observational
  20. Vitamin D, parathyroid hormone and cardiovascular risk: the good, the bad and the ugly.Journal of cardiovascular medicine (Hagerstown, Md.) · 2018
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Lorraine A FitzpatrickResearch and Development, Musculoskeletal Diseases, GlaxoSmithKline, 2301 Renaissance Boulevard, RN0420, King of Prussia, PA 19406, USA. lorraine.a.fitzpatrick@gsk.com
John P Bilezikian
Shonni J Silverberg
GlaxoSmithKline (United Kingdom) · GB

Funding

PRIMARY HYPERPARATHYROIDISM: NON-CLASSICAL MANIFESTATIONSR01DK066329 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERBERG, SHONNI J · 2005 to 2009
$2.6M
NIDDK NIH HHS R01 DK066329
6 · The paper itself

Abstract

The classical actions of parathyroid hormone (PTH) are well recognized, but its effects on other target tissues, such as the cardiovascular system, are less appreciated. Several studies have evaluated the effects of PTH in patients with primary hyperparathyroidism in order to understand potential cardiovascular effects in terms of hypertension, cardiovascular mortality, left ventricular function, and endothelial function. We review these studies and evaluate the cellular mechanisms that may affect these outcomes.

Indexed as

AnimalsCardiovascular DiseasesCardiovascular SystemDisease Models, AnimalHumansHyperparathyroidismHypertensionParathyroid HormoneVentricular Dysfunction, LeftParathyroid Hormone

Identifiers

PMID18778568
OpenAlexW2066055420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.